|
|
|
|
|
|
|
|
|
|
The Institutional BioSafety Committee (IBC) oversees the use of recombinant DNA technology, infectious agents, select agents, and biological toxins in research procedures conducted at or supported by the University of South Florida. All work involving the use of these materials must be registered with and reviewed by the IBC. |
| Submission Deadline | Scheduled Meetings |
| December 4 | December 15 |
| Submission Deadline | Scheduled Meetings |
| January 8 | January 19 |
| February 5 | February 16 |
| March 5 | March 16 |
| April 9 | April 20 |
| May 7 | May 18 |
| June 4 | June 15 |
| July 9 | July 20 |
| August 6 | August 17 |
| September 10 | September 21 |
| October 8 | October 19 |
| November 5 | November 16 |
| December 3 | December 14 |
| Please address all questions to
Farah Moulvi at
(813) 974-0954 or e-mail: fmoulvi@research.usf.edu |
 |
 |
Division of Research Integrity & Compliance
|
Copyright © 2009, University of South Florida. All rights reserved. |
Direct questions or comments about this Web site to jarnaldi@research.usf.edu Last updated: November 18, 2009 |